Environmental Engineering Reference
In-Depth Information
References
alkire, Sabina and lincoln chen (2004). 'Global Health and Moral values.'
Lancet,
vol. 364,
no. 9439, pp. 1069-1074.
angell, Marcia (2004).
The Truth About the Drug Companies: How They Deceive Us and
What to Do About It
. (new York: random House).
bloche, M. Gregg (2002). 'wto Deference to national Health Policy: toward an Interpretive
Principle.'
Journal of International Economic Law,
vol. 5, no. 4, pp. 825-848.
chirac, Pierre and els torreele (2006). 'Global Framework on essential Health r&D.'
Lancet,
vol. 367, no. 9522, pp. 1560-1561.
commission on Intellectual Property rights, Innovation, and Public Health (2006).
Public
Health: Innovation and Intellectual Property Rights.
World Health Organization, Geneva.
<www.who.int/entity/intellectualproperty/documents/thereport/enPublicHealthreport.
pdf> (September 2008).
cullet, Philippe (2003). 'Patents and Medicines: the relationship between trIPS and the
Human right to Health.'
International Affairs,
vol. 79, no. 1, pp. 139-160.
Drahos, Peter (2001). 'bilateralism in Intellectual Property.' Paper prepared for cut the cost
of Medicines campaign. oxfam Gb, london. <www.maketradefair.com/assets/english/
bilateralism.pdf> (September 2008).
Fisher, richard w. (1999). 'technological Progress and american rights: trade Policy and
Intellectual Property Protection.' testimony before the Subcommittee on International
economic Policy and trade House committee on International relations, 13 october.
washington Dc.
Médecins Sans Frontières (2001).
Fatal Imbalance: The Crisis in Research Development for
Drugs for Neglected Diseases.
Geneva. <www.msf.org/source/access/2001/fatal/fatal.
pdf> (September 2008).
Médecins Sans Frontières (2003).
Doha Derailed: A Progress Report on TRIPS and Access
to Medicines.
27 August. Geneva. <www.accessmed-msf.org/ileadmin/user_upload/
medinnov_accesspatents/cancunbrieing.pdf> (September 2008).
oxfam International (2007). 'Investing for life: Meeting Poor People's needs for
Access to Medicines Through Responsible Business Practices.' Briefing Paper 109.
oxfam International. <www.oxfam.org.uk/resources/policy/health/bp109_pharma.html>
(September 2008).
Redwood, Heinz (1995).
Brazil: The Future Impact of Pharmaceutical Patents
. (Suffolk:
oldwicks Press).
rodrik, Dani (1997).
Has Globalization Gone Too Far?
(washington Dc: Institute for
International economics).
Saul, John ralston (2005).
The Collapse of Globalism and the Reinvention of the World
.
(toronto: viking canada).
Scherer, Frederick M. (2000). 'the Pharmaceutical Industry.' In a.J. culyer and J.P. newhouse,
eds.,
Handbook of Health Economics
(new York: elsevier Science).
Shalden, Ken (2007). 'the Political economy of aIDS treatment.'
International Studies
Quarterly,
vol. 51, no. 3, pp. 559-581.
Stiglitz, Joseph (2006).
Making Globalization Work
. (new York: w.w. norton).
trouiller, Patrice, Piero olliaro, els torreele
,
et al. (2002). 'neglected Diseases and
Pharmaceuticals: Between Deficient Market and Public Health Failure.'
Lancet,
vol. 359,
no. 9324, pp. 2188-2194.
